Kathy Yi - Oct 6, 2021 Form 3 Insider Report for Theseus Pharmaceuticals, Inc. (THRX)

Role
Director
Signature
/s/ Bradford Dahms - Attorney-in-Fact
Stock symbol
THRX
Transactions as of
Oct 6, 2021
Transactions value $
$0
Form type
3
Date filed
10/6/2021, 07:00 PM
Next filing
Jun 13, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding THRX Stock Option (right to buy) Oct 6, 2021 Common Stock 99.6K $4.03 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The options are subject to a service-based vesting requirement, which shall be satisfied over a three-year period with 1/36th of the options vesting monthly after May 31, 2021, subject to the Reporting Person's continuous service with the issuer.